Trial no.:
|
PACTR202101553712948 |
Date of Approval:
|
28/01/2021 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Extra virgin olive oil effect on nipples |
Official scientific title |
Effect of Application of Extra Virgin Olive Oil (Evoo) versus expressed breast milk (EBM) on painful and damaged nipples during lactation |
Brief summary describing the background
and objectives of the trial
|
Nipple damage, which includes pain or cracks, and soreness are common problems that frequently occur after breastfeeding. When the nipples are injured, breastfeeding is put in danger. It is estimated that 34%–96% of breastfeeding women experience nipple soreness that may resort to premature weaning. Moreover, up to one-third of mothers who experience these problems may change to other methods of infant nutrition within the first 6 weeks postnatal.
Extra virgin olive oil (EVOO) has immunological, anti-inflammatory, antioxidant, antibacterial, and antifungal properties. It has been used by researchers for the prevention and treatment of nipple trauma since it is an easily attainable and relatively inexpensive substance. Moreover, it had been used for sore nipples in Mediterranean countries for years.
Breast milk (BM) is also used for preventing and treating nipple trauma, due to its healing elements, such as growth factors, anti-inflammatory, and anti-microbial substances. These protective factors help explain the effects of breast milk in healing nipple trauma in breastfeeding women. Thus, we aimed to evaluate the effectiveness of the application of EVOO versus BM on nipple trauma and pain among lactating women.
The aim of this work is to evaluate the effect of extra virgin olive oil compared to breast milk on painful and damaged nipples during lactation.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology,Skin and Connective Tissue Diseases |
Sub-Disease(s) or condition(s) being studied |
Breast feeding |
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
25/09/2019 |
Actual trial start date |
25/09/2019 |
Anticipated date of last follow up |
25/12/2019 |
Actual Last follow-up date |
25/12/2019 |
Anticipated target sample size (number of participants) |
120 |
Actual target sample size (number of participants) |
120 |
Recruitment status |
Completed |
Publication URL |
|
|